Osimertinib vs Rosuvastatin
Osimertinib vs Rosuvastatin: Overview
This comparison examines the pharmacological differences between Osimertinib and Rosuvastatin.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Rosuvastatin: Competitive inhibitor of HMG-CoA reductase.
Pharmacokinetics
Half-life: Osimertinib — 48 hours; Rosuvastatin — 19 hours.
Chemical Properties
Molecular Formula: Osimertinib — C28H33N7O2; Rosuvastatin — C22H28FN3O6S.
Molecular Weight: Osimertinib — 499.6050 g/mol; Rosuvastatin — 481.5390 g/mol.
Type: Osimertinib — Small molecule; Rosuvastatin — Small molecule.